BC Extra | Sep 20, 2019
Company News

Sept. 20 Company Quick Takes: Three Japanese approvals, plus AZ-Ironwood, Boehringer-Inflammasome, China Biologics and a Sino-Russian JV

Japanese approvals include Tecentriq for TNBC  Japan’s Ministry of Health, Labour and Welfare expanded the label of Tecentriq atezolizumab from Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) to include PD-L1-positive triple-negative breast cancer. MHLW also approved serotonin...
BC Week In Review | Jan 4, 2019
Financial News

Shanghai Industrial Investment plans $7.3B biomedical fund

Shanghai Industrial Investment (Holdings) Co. Ltd. (Shanghai, China) plans to launch a $7.3 billion biomedical direct investment fund. It expects to begin raising the fund's first $1.5 billion tranche in January. President Jun Zhou announced...
BC Extra | Dec 31, 2018
Financial News

Shanghai Industrial Investment plans $7.3B biomedical fund

Shanghai Industrial Investment (Holdings) Co. Ltd. (Shanghai, China) plans to launch a $7.3 billion biomedical direct investment fund. It expects to begin raising the fund's first $1.5 billion tranche in January. President Jun Zhou announced...
BC Week In Review | May 25, 2018
Company News

Takeda divests stake in Chinese JV Techpool

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on May 23 that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China) does not signal a...
BC Extra | May 23, 2018
Company News

Takeda divests stake in Chinese JV

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on Wednesday that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China) does not signal a strategic...
BC Week In Review | Feb 2, 2018
Financial News

Shanghai Pharmaceuticals raises HK$3.1B placement

Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) raised HK$3.1 billion ($400.2 million) on Jan. 26 through the sale of 153.2 million shares at HK$20.43 in a placement on the Hong Kong stock exchange. The price...
BC Week In Review | Dec 8, 2017
Company News

J&J to launch JLABS incubator in Shanghai

The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson (NYSE:JNJ) will launch JLABS @ Shanghai, a JLABS incubator in Shanghai, China. The facility, slated to open in 2Q19, will be the first JLABS...
BC Extra | Dec 5, 2017
Company News

J&J to launch JLABS incubator in Shanghai

The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson (NYSE:JNJ) will launch JLABS @ Shanghai, a JLABS incubator in Shanghai, China. The facility, slated to open in 2Q19, will be the first JLABS...
BC Week In Review | Nov 17, 2017
Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
BC Extra | Nov 15, 2017
Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
Items per page:
1 - 10 of 21
BC Extra | Sep 20, 2019
Company News

Sept. 20 Company Quick Takes: Three Japanese approvals, plus AZ-Ironwood, Boehringer-Inflammasome, China Biologics and a Sino-Russian JV

Japanese approvals include Tecentriq for TNBC  Japan’s Ministry of Health, Labour and Welfare expanded the label of Tecentriq atezolizumab from Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) to include PD-L1-positive triple-negative breast cancer. MHLW also approved serotonin...
BC Week In Review | Jan 4, 2019
Financial News

Shanghai Industrial Investment plans $7.3B biomedical fund

Shanghai Industrial Investment (Holdings) Co. Ltd. (Shanghai, China) plans to launch a $7.3 billion biomedical direct investment fund. It expects to begin raising the fund's first $1.5 billion tranche in January. President Jun Zhou announced...
BC Extra | Dec 31, 2018
Financial News

Shanghai Industrial Investment plans $7.3B biomedical fund

Shanghai Industrial Investment (Holdings) Co. Ltd. (Shanghai, China) plans to launch a $7.3 billion biomedical direct investment fund. It expects to begin raising the fund's first $1.5 billion tranche in January. President Jun Zhou announced...
BC Week In Review | May 25, 2018
Company News

Takeda divests stake in Chinese JV Techpool

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on May 23 that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China) does not signal a...
BC Extra | May 23, 2018
Company News

Takeda divests stake in Chinese JV

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on Wednesday that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China) does not signal a strategic...
BC Week In Review | Feb 2, 2018
Financial News

Shanghai Pharmaceuticals raises HK$3.1B placement

Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) raised HK$3.1 billion ($400.2 million) on Jan. 26 through the sale of 153.2 million shares at HK$20.43 in a placement on the Hong Kong stock exchange. The price...
BC Week In Review | Dec 8, 2017
Company News

J&J to launch JLABS incubator in Shanghai

The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson (NYSE:JNJ) will launch JLABS @ Shanghai, a JLABS incubator in Shanghai, China. The facility, slated to open in 2Q19, will be the first JLABS...
BC Extra | Dec 5, 2017
Company News

J&J to launch JLABS incubator in Shanghai

The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson (NYSE:JNJ) will launch JLABS @ Shanghai, a JLABS incubator in Shanghai, China. The facility, slated to open in 2Q19, will be the first JLABS...
BC Week In Review | Nov 17, 2017
Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
BC Extra | Nov 15, 2017
Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
Items per page:
1 - 10 of 21